| 1 |
Laessle C, Schneider J, Pisarski P, et al. Experiences and short-term outcome of kidney transplantation during Covid-19 pandemic from a medium volume transplantation and supraregional Covid-19 treatment center[J]. Transplant Proc, 2021, 53(4)：1146-1153.
|
| 2 |
Zarifi SH, Shadnoush M, Pahlavani N, et al. Nutritional status in kidney transplant patients before and 6-month after transplantation: result of PNSI study[J]. Clin Nutr ESPEN, 2021, 41：268-274.
|
| 3 |
朱宗玲， 王艳艳. 合并肺结核的一例castleman病[C]//中华医学会，中华临床医师杂志(电子版)编辑. 2016全国慢性病诊疗论坛论文汇编， 昆明， 2016：34-35.
|
| 4 |
Aguado JM, Torre-Cisneros J, Fortún J, et al. Tuberculosis in solid-organ transplant recipients: consensus statement of the group for the study of infection in transplant recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology[J]. Clin Infect Dis, 2009, 48(9)：1276.
|
| 5 |
Subramanian AK, Morris MI; AST Infectious Diseases Community of Practice. Mycobacterium tuberculosis infections in solid organ transplantation[J]. Am J Transplant, 2013，13(Suppl 4): S68-S76.
|
| 6 |
Torre-Cisneros J, Doblas A, Aguado JM, et al. Tuberculosis after solid-organ transplant: incidence, risk factors, and clinical characteristics in the RESITRA (Spanish Network of Infection in Transplantation) cohort[J]. Clin Infect Dis, 2009, 48(12)：1657-1665.
|
| 7 |
Adami J, Gäbel H, Lindelöf B, et al. Cancer risk following organ transplantation: a nationwide cohort study in Sweden[J]. Br J Cancer, 2003, 89(7): 1221.
|
| 8 |
Gentil Govantes MA, Vidal Blandino M, Ruiz Esteban P, et al. Associated characteristics and impact on survival of post renal-transplantation lymphoproliferative disease: case-control study from a regional registry[J]. Transplant Proc，2013, 45(10)：3624-3626.
|
| 9 |
Seidemann K, Tiemann M, Henze G, et al. Therapy for non-Hodgkin lymphoma in children with primary immunodeficiency: analysis of 19 patients from the BFM trials[J]. Med Pediatr Oncol, 1999, 33(6)：536-544.
|
| 10 |
Gerrard M, Cairo MS, Weston C, et al. Excellent survival following two courses of COPAD chemotherapy in children and adolescents with resected localized B-cell non-Hodgkin′s lymphoma: results of the FAB/LMB 96 international study[J]. Br J Haematol, 2008, 141(6): 840-847.
|
| 11 |
张静怡，徐珽. 临床药师参与1例肾移植术后肺结核患者抗结核治疗的药学实践[J]．药物流行病学杂志， 2018, 27(7): 474-478.
|
| 12 |
方佳丽， 陈正， 马俊杰， 等. 肾移植术后肺结核及肺外结核的诊治[J]. 实用医院临床杂志， 2011, 8(6)：11-14.
|
| 13 |
安丹， 韩梦霞， 张韬．肾移植术后并发肺结核11例临床分析[J]．人民军医， 2008, 51(6)：390.
|
| 14 |
Opelz G, Henderson R. Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients[J]. Lancet, 1993, 342(8886-8887)：1514-1516.
|
| 15 |
崔力方，张继新， 昌红， 等. 肾移植后淋巴组织增生性疾病2例临床病理观察[J]．诊断病理学杂志， 2015, 22(8)：467-470.
|
| 16 |
Schlieper G, Kurschat C, Donner A, et al. Hodgkin disease-like posttransplantation lymphoproliferative disorder of donor origin in a renal allograft recipient[J]. Am J Kidney Dis, 2006, 47(3): e37-e41.
|